Atlas Trials

Inmunova S.A.

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Inmunova S.A.

RecordFirmDate
A Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 in Pediatric Patients With STEC-HUS (NCT05569746)Inmunova S.A.2022-10-06
Effectiveness and Safety Study of Specific Hyperimmune Equine Serum for the Treatment of Severe Hospitalized SARS-CoV-2 in Adults: Retrospective Cohort Study (NCT04954235)Inmunova S.A.2021-05-22
A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19. (NCT04494984)Inmunova S.A.2020-07-27
Phase 2/3 Study to Evaluate PK, Safety & Efficacy of INM004 in STEC Positive Pediatric Patients for Prevention of HUS (NCT04132375)Inmunova S.A.2019-07-17
Anti-Shiga Toxin Hyperimmune Equine Immunoglobulin F(ab')2 Fragment (INM004) in Healthy Volunteers (NCT03388216)Inmunova S.A.2017-12-16

Track Inmunova S.A. automatically

Every clearance here is in the API, with alerts when new ones post.